In the ever-evolving world of medicine, breakthroughs in pharmaceuticals continue to provide hope and relief to patients facing challenging health conditions. One such innovation is the Kineret Injection, also known as anakinra injection. This remarkable medication, powered by the active…
In the ever-evolving landscape of cancer treatment, groundbreaking advancements bring renewed hope to patients and healthcare professionals alike. One such recent development is Tukysa 150 mg, a medication that is revolutionizing the way we approach cancer therapy. In this blog,…
In the world of healthcare, hope often takes the form of access to life-saving medications, especially for those who suffer from rare diseases. In this blog, we will introduce you to Hayat Alhikmah, a dedicated rare disease medicine supplier, and…
In the world of pharmaceuticals, the backbone of efficient healthcare delivery is a well-structured distribution network. Hayat Alhikmah, a GDP-certified company, stands as a beacon of excellence in the wholesale distribution of pharmaceutical products. With a commitment to quality and…
Thrombocythemia, a condition characterized by an abnormal increase in platelet production in the blood, can be a challenging diagnosis to manage. Fortunately, medical science continues to advance, offering innovative treatments to improve the quality of life for those affected. One…
A 42% of patients with heart failure have depression symptoms, a common co-morbidity linked to poor quality of life and a bad prognosis. In addition to having an adverse effect on everyday social and domestic activities, 1-3 depressive symptoms significantly…
Enhertu is the first specific treatment for HER2-mutant lung cancer. Enhertu is the chemical name of fam-trastuzumab-deruxtecan-nxki. When referring to the generic medicine name trastuzumab deruxtecan, healthcare practitioners may use the commercial name Enhertu. A drug is chemically joined to…
Venetoclax is a chemotherapy drug that slows the growth of cancer cells in one of three ways. It either kills the cancer cells or stops them from growing or spreading. Giving venetoclax with rituximab may increase the death of cancer…
Cystic fibrosis has inflammation as one of its primary pathological drivers. Current treatments are poor at controlling and halting the progression of inflammatory events, frequently made worse by concurrent infection. Using anakinra, a non-glycosylated recombinant version of IL-1Ra, offers a…
The pathophysiology of cardiovascular disease and protein-energy wasting, which are significant risk factors for morbidity and mortality in individuals with end-stage kidney disease, are linked to inflammation. Anti-cytokine therapy has been proposed to reduce inflammation and improve outcomes. Anakinra’s effectiveness,…
Subscribe to our
Newsletter
***We Promise, no spam!
We are pharmaceutical wholesaler based in Dubai with a sister company based in India. We bridge the geographical gaps for our customers by providing easy access of Generic drugs, Reference listed drug and Name patient Import service, along with temperature controlled product.
Quick Contacts
- Warehouse No. 4 Street No. 27, Al Qusais Industrial Area 1, Dubai, United Arab Emirates.
- +971 54 2188305
- +971 04 269 4022
- [email protected]
© 2023 Hayatalhikmah | All Rights Reserved.